{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:17:18Z","timestamp":1772126238555,"version":"3.50.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"abstract":"<jats:p>To investigate the use of lipid-lowering drugs and abnormal serum lipid levels in patients at risk of sleep apnea syndrome. Three types of Mendelian randomization (MR) analyses were used. First, a 2-sample Mendelian randomization (TSMR) analysis was used to investigate the association between sleep apnea syndrome risk and serum lipid levels. Multivariate Mendelian randomization (MVMR) analysis was subsequently used to investigate the effects of confounding variables on SAS incidence of sleep apnea syndrome. Finally, drug-target Mendelian randomization (DMR) analysis was used to analyze the association between lipid-lowering drug use and sleep apnea syndrome risk. According to the TSMR analysis, the serum HDL-C concentration was negatively correlated with sleep apnea syndrome (OR\u2005=\u20050.904; 95% CI\u2005=\u20050.845\u20130.967; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.003). Serum TG levels were positively correlated with sleep apnea syndrome (OR\u2005=\u20051.081; 95% CI\u2005=\u20051.003\u20131.163; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.039). The association between serum HDL-C levels and sleep apnea syndrome in patients with MVMR was consistent with the results in patients with TSMR (OR\u2005=\u20050.731; 95% CI\u2005=\u20050.500\u20131.071; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20053.94E\u221205). According to our DMR analysis, HMGCR and PCSK9, which act by lowering serum LDL-C levels, were inversely associated with the risk of sleep apnea syndrome (OR\u2005=\u20050.627; 95% CI\u2005=\u20050.511\u20130.767; <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>=\u20056.30E\u221206) (OR\u2005=\u20050.775; 95% CI\u2005=\u20050.677\u20130.888; <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>=\u2005.0002). LPL, that lowered serum TG levels, was positively associated with the risk of sleep apnea syndrome (OR\u2005=\u20051.193; 95% CI\u2005=\u20051.101\u20131.294; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20051.77E\u221205). Our analysis suggested that high serum HDL-C levels may reduce the risk of sleep apnea syndrome. Low serum TG levels have a protective effect against sleep apnea syndrome. The DMR results suggested that the use of HMGCR lipid-lowering drugs (such as statins) and PCSK9 inhibitors has a protective effect against sleep apnea syndrome. However, LPL-based lipid-lowering drugs may increase the risk of sleep apnea syndrome.<\/jats:p>","DOI":"10.1097\/md.0000000000040194","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:04:38Z","timestamp":1730214278000},"page":"e40194","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the effects of HMGCR, LPL, and PCSK9 inhibition on sleep apnea: Mendelian randomization analysis of drug targets"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2761-0641","authenticated-orcid":false,"given":"Wei","family":"Tan","sequence":"first","affiliation":[{"name":"Graduate School, Hunan University of Chinese Medicine, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoning","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangbo","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/resp.13838","article-title":"Global burden of sleep-disordered breathing and its implications.","volume":"25","author":"Lyons","year":"2020","journal-title":"Respirology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200202073460602","article-title":"Sleep apnea syndrome.","volume":"346","author":"Drazen","year":"2002","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1088\/1361-6579\/aa6ec6","article-title":"Sleep apnea: a review of diagnostic sensors, algorithms, and therapies.","volume":"38","author":"Shokoueinejad","year":"2017","journal-title":"Physiol Meas"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11325-021-02429-6","article-title":"Interactions of central and autonomic nervous systems in patients with sleep apnea-hypopnea syndrome during sleep.","volume":"26","author":"Wang","year":"2022","journal-title":"Sleep Breath"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/resp.13372","article-title":"Obstructive sleep apnoea independently predicts lipid levels: data from the European Sleep Apnea Database.","volume":"23","author":"G\u00fcnd\u00fcz","year":"2018","journal-title":"Respirology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"897279","DOI":"10.3389\/fphar.2022.897279","article-title":"Correlation of dyslipidemia and inflammation with obstructive sleep apnea severity.","volume":"13","author":"Popadic","year":"2022","journal-title":"Front Pharmacol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/0278-7393.15.1.137","article-title":"Bizarre imagery, interference, and distinctiveness.","volume":"15","author":"Einstein","year":"1989","journal-title":"J Exp Psychol Learn Mem Cogn"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000524087","article-title":"Effects of apnea, obesity, and statin therapy on proprotein convertase Subtilisin\/Kexin 9 levels in patients with obstructive sleep apnea.","volume":"31","author":"Milojevi\u0107","year":"2022","journal-title":"Med Princ Pract"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosissup.2015.02.003","article-title":"PCSK9 antibodies: a new class of lipid-lowering drugs.","volume":"18","author":"Gouni-Berthold","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"eabe9117","DOI":"10.1126\/scitranslmed.abe9117","article-title":"An oral antisense oligonucleotide for PCSK9 inhibition.","volume":"13","author":"Gennemark","year":"2021","journal-title":"Sci Transl Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4093\/dmj.2022.0198","article-title":"New, novel lipid-lowering agents for reducing cardiovascular risk: beyond statins.","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab J"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pharmthera.2016.04.011","article-title":"Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol.","volume":"164","author":"Della Badia","year":"2016","journal-title":"Pharmacol Ther"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/CIRCULATIONAHA.122.063372","article-title":"Orally bioavailable macrocyclic peptide that inhibits binding of PCSK9 to the low density lipoprotein receptor.","volume":"148","author":"Johns","year":"2023","journal-title":"Circulation"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/ATVBAHA.115.306032","article-title":"PCSK9 Induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver.","volume":"35","author":"Demers","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"113957","DOI":"10.1016\/j.biopha.2022.113957","article-title":"Safety of PCSK9 inhibitors.","volume":"156","author":"Grze\u015bk","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e000028","DOI":"10.1161\/JAHA.112.000028","article-title":"Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy.","volume":"2","author":"Raal","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"188351","DOI":"10.1016\/j.bbcan.2020.188351","article-title":"Cholesterol and beyond \u2013 the role of the mevalonate pathway in cancer biology.","volume":"1873","author":"G\u00f6bel","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-020-2928-y","article-title":"Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis.","volume":"588","author":"Lu","year":"2020","journal-title":"Nature"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2022.6051","article-title":"Association of lipid-lowering drugs with risk of psoriasis: a Mendelian randomization study.","volume":"159","author":"Zhao","year":"2023","journal-title":"JAMA Dermatol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e73873","DOI":"10.7554\/eLife.73873","article-title":"Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.","volume":"10","author":"Huang","year":"2021","journal-title":"Elife"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2022.05.041","article-title":"Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function.","volume":"80","author":"Rosoff","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(02)00046-3","article-title":"Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia.","volume":"320","author":"Salazar","year":"2002","journal-title":"Clin Chim Acta"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41588-020-0631-4","article-title":"Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics.","volume":"52","author":"Morrison","year":"2020","journal-title":"Nat Genet"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/STROKEAHA.120.032617","article-title":"Mendelian randomization studies in stroke: exploration of risk factors and drug targets with human genetic data.","volume":"52","author":"Georgakis","year":"2021","journal-title":"Stroke"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.26426","article-title":"Lipids, apolipoproteins, statins, and intracerebral hemorrhage: a mendelian randomization study.","volume":"92","author":"Yu","year":"2022","journal-title":"Ann Neurol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"115295","DOI":"10.1007\/s11356-023-30546-0","article-title":"Association of exposures to serum terpenes with the prevalence of dyslipidemia: a population-based analysis.","volume":"30","author":"Ba","year":"2023","journal-title":"Environ Sci Pollut Res Int"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s10194-023-01633-x","article-title":"Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study.","volume":"24","author":"Bi","year":"2023","journal-title":"J Headache Pain"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels.","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants.","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinformatics"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals.","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"a038984","DOI":"10.1101\/cshperspect.a038984","article-title":"Multivariable Mendelian randomization and mediation.","volume":"11","author":"Sanderson","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease.","volume":"45","author":"Do","year":"2013","journal-title":"Nat Genet"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression.","volume":"47","author":"Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5664\/jcsm.8130","article-title":"Prevalence of risk for sleep apnea among hospitalized patients who survived a medical emergency team activation.","volume":"16","author":"Tang","year":"2020","journal-title":"J Clin Sleep Med"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00063198-199511000-00009","article-title":"Epidemiology of obstructive sleep apnea syndrome.","volume":"1","author":"Partinen","year":"1995","journal-title":"Curr Opin Pulm Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/svn-2016-000038","article-title":"Sleep apnoea and stroke.","volume":"1","author":"Sharma","year":"2016","journal-title":"Stroke Vasc Neurol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"zsy236","DOI":"10.1093\/sleep\/zsy236","article-title":"Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence.","volume":"42","author":"Barros","year":"2019","journal-title":"Sleep"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2147\/NSS.S327478","article-title":"The association of obstructive sleep apnea and nocturnal hypoxemia with lipid profiles in a population-based study of community-dwelling Australian men.","volume":"13","author":"Guscoth","year":"2021","journal-title":"Nat Sci Sleep"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.metabol.2011.06.004","article-title":"Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol.","volume":"61","author":"Kawano","year":"2012","journal-title":"Metabolism"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1513\/AnnalsATS.202209-761OC","article-title":"Statins restore endothelial protection against complement activity in obstructive sleep apnea: a randomized clinical trial.","volume":"20","author":"Shah","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity.","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"376","DOI":"10.23736\/S0031-0808.20.03932-4","article-title":"Efficacy of statin therapy in chronic obstructive pulmonary disease: a systematic review and meta-analysis from 2008-2019.","volume":"65","author":"Xue","year":"2023","journal-title":"Panminerva Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:55:10Z","timestamp":1746320110000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":43,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040194","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}